HCP:NYE-HCP Inc.

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 36.84

Change

+0.13 (+0.35)%

Market Cap

USD 13.60B

Volume

2.83M

Analyst Target

USD 35.72
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCP Inc is a real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. Its business segments are senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.30 (+0.32%)

USD 52.38B
VTR Ventas Inc

-0.25 (-0.57%)

USD 17.31B
DOC Healthpeak Properties Inc

-0.29 (-1.56%)

USD 12.76B
OHI Omega Healthcare Investors Inc

+0.22 (+0.72%)

USD 7.67B
HR Healthcare Realty Trust Incorp..

-0.35 (-2.43%)

USD 5.39B
CTRE CareTrust REIT Inc.

+0.14 (+0.59%)

USD 3.24B
NHI National Health Investors Inc

-0.24 (-0.38%)

USD 2.54B
MPW Medical Properties Trust Inc

-0.01 (-0.22%)

USD 2.43B
AHR American Healthcare REIT Inc

N/A

USD 1.64B
LTC LTC Properties Inc

-0.05 (-0.16%)

USD 1.38B

ETFs Containing HCP

W1TB:XETRA WisdomTree Cybersecurity .. 5.18 % 0.00 %

-0.41 (-1.76%)

USD 0.19B
WCBR WisdomTree Cybersecurity .. 4.87 % 0.00 %

-0.17 (-1.76%)

USD 0.10B
CYSE:LSE WisdomTree Cybersecurity .. 0.00 % 0.00 %

-29.60 (-1.76%)

USD 0.20B
WCBR:LSE WisdomTree Cybersecurity .. 0.00 % 0.00 %

-0.37 (-1.76%)

USD 0.20B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.90% 85% B 86% B+
Dividend Return 3.97% 38% F 77% C+
Total Return 35.88% 85% B 87% B+
Trailing 12 Months  
Capital Gain 43.46% 77% C+ 95% A
Dividend Return 5.76% 77% C+ 83% B
Total Return 49.22% 85% B 96% N/A
Trailing 5 Years  
Capital Gain -13.54% 18% F 30% F
Dividend Return 21.05% 9% A- 69% C-
Total Return 7.51% 18% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain -4.86% 8% B- 19% F
Dividend Return 0.54% 8% B- 28% F
Total Return 5.40% 69% C- 83% B
Risk Return Profile  
Volatility (Standard Deviation) 20.95% 23% F 35% F
Risk Adjusted Return 2.56% 8% B- 26% F
Market Capitalization 13.60B 86% B+ 89% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.98 86% 52%
Price/Book Ratio 2.82 29% 30%
Price / Cash Flow Ratio 20.02 43% 19%
Price/Free Cash Flow Ratio 24.81 29% 14%
Management Effectiveness  
Return on Equity 16.49% 93% 80%
Return on Invested Capital 4.12% 50% 36%
Return on Assets 1.93% 29% 38%
Debt to Equity Ratio 92.10% 57% 39%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.